基于互联网的诱发性乳腺炎治疗:与治疗结果相关的因素
Andrea Hess Engström1, Ida Flink2, Viktoria Kero1
1Department of Women's and Children's Health, Uppsala University, 752 37, Sweden.
The journal of sexual medicine
|November 13, 2024
概括
这项研究探讨了在接受互联网基于接受和承诺疗法 (ACT) 的诱发性乳腺炎患者中影响疼痛接受的因素. 经过统计调整后,没有任何个体特征与改善疼痛接受有显著联系.
科学领域:
- 心理学 心理学 心理学
- 医学研究 医学研究
- 数字健康数字健康
背景情况:
- 基于互联网的接受和承诺疗法 (ACT) 显示出减轻疼痛和增加疼痛接受的承诺.
- 然而,影响这些治疗结果的因素在很大程度上是未知的.
研究的目的:
- 为了调查社会人口统计学,医疗,行为和心理社会因素,与变化疼痛接受在基于互联网的ACT后诱发性.
主要方法:
- 从一个多中心随机对照试验 (EMBLA研究) 的数据的探索性分析.
- 线性回归模型评估了各种因素与疼痛接受 (活动参与,疼痛意愿) 之间的关联.
- 对多次测试的结果进行了调整,使用邦费罗尼校正.
主要成果:
- 在调整之前,暴力史,治疗平台参与度增加和胃肠道问题等因素与改善疼痛接受度有关.
- 相反,年龄较大和尿道问题与疼痛意愿的改善较少相关.
- 在多次测试的邦费罗尼校正后,没有任何关联在统计学上仍然显著.
结论:
- 虽然初步分析表明了潜在的影响因素,但严格的统计调整显示没有显著的关联.
- 需要对更大的样本进行进一步的研究,以确认或反驳对先前创伤和坚持等因素的初步发现.
- 该研究强调,需要继续调查影响诱发性乳腺炎治疗结果的个体特征.
相关概念视频
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...